128 related articles for article (PubMed ID: 21532323)
1. An innate bactericidal oleic acid effective against skin infection of methicillin-resistant Staphylococcus aureus: a therapy concordant with evolutionary medicine.
Chen CH; Wang Y; Nakatsuji T; Liu YT; Zouboulis C; Gallo R; Zhang L; Hsieh MF; Huang CM
J Microbiol Biotechnol; 2011 Apr; 21(4):391-9. PubMed ID: 21532323
[TBL] [Abstract][Full Text] [Related]
2. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
Desbois AP; Gemmell CG; Coote PJ
Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
Park YS; Shin WS; Kim SK
J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852
[TBL] [Abstract][Full Text] [Related]
4. LysGH15 reduces the inflammation caused by lethal methicillin-resistant Staphylococcus aureus infection in mice.
Gu J; Zuo J; Lei L; Zhao H; Sun C; Feng X; Du C; Li X; Yang Y; Han W
Bioeng Bugs; 2011; 2(2):96-9. PubMed ID: 21636996
[TBL] [Abstract][Full Text] [Related]
5. In vivo activity of a novel polymeric guanidine in experimental skin infection with methicillin-resistant Staphylococcus aureus.
Kratzer C; Tobudic S; Macfelda K; Graninger W; Georgopoulos A
Antimicrob Agents Chemother; 2007 Sep; 51(9):3437-9. PubMed ID: 17620381
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis.
Jacqueline C; Amador G; Caillon J; Le Mabecque V; Batard E; Miègeville AF; Biek D; Ge Y; Potel G; Hamel A
J Antimicrob Chemother; 2010 Aug; 65(8):1749-52. PubMed ID: 20530506
[TBL] [Abstract][Full Text] [Related]
7. Anti-infectious activity of synbiotics in a novel mouse model of methicillin-resistant Staphylococcus aureus infection.
Lkhagvadorj E; Nagata S; Wada M; Bian L; Wang C; Chiba Y; Yamashiro Y; Shimizu T; Asahara T; Nomoto K
Microbiol Immunol; 2010 May; 54(5):265-75. PubMed ID: 20536723
[TBL] [Abstract][Full Text] [Related]
8. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.
Scheinfeld N
J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Jacqueline C; Amador G; Batard E; Le Mabecque V; Miègeville AF; Biek D; Caillon J; Potel G
J Antimicrob Chemother; 2011 Apr; 66(4):863-6. PubMed ID: 21393213
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
Lefebvre M; Jacqueline C; Amador G; Le Mabecque V; Miegeville A; Potel G; Caillon J; Asseray N
Int J Antimicrob Agents; 2010 Dec; 36(6):542-4. PubMed ID: 20851576
[TBL] [Abstract][Full Text] [Related]
11. Methicillin-resistant Staphylococcus aureus: the superbug.
Ippolito G; Leone S; Lauria FN; Nicastri E; Wenzel RP
Int J Infect Dis; 2010 Oct; 14 Suppl 4():S7-11. PubMed ID: 20851011
[TBL] [Abstract][Full Text] [Related]
12. Ceftaroline for complicated skin and skin-structure infections.
Nannini EC; Stryjewski ME; Corey GR
Expert Opin Pharmacother; 2010 May; 11(7):1197-206. PubMed ID: 20402556
[TBL] [Abstract][Full Text] [Related]
13. New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus.
Bouza E
Clin Microbiol Infect; 2009 Dec; 15 Suppl 7():44-52. PubMed ID: 19951334
[TBL] [Abstract][Full Text] [Related]
14. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial effect of octylcyanoacrylate against methicillin-resistant Staphylococcus aureus isolates from patients with chronic suppurative otitis media.
Jang CH; Park H; Choi CH; Cho YB; Park IY
In Vivo; 2008; 22(6):763-5. PubMed ID: 19181004
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections.
Deresinski S
Clin Infect Dis; 2009 Oct; 49(7):1072-9. PubMed ID: 19725789
[TBL] [Abstract][Full Text] [Related]
17. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
Lawrence KR; Golik MV; Davidson L
Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
[TBL] [Abstract][Full Text] [Related]
18. Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment.
Sarikonda KV; Micek ST; Doherty JA; Reichley RM; Warren D; Kollef MH
Crit Care Med; 2010 Oct; 38(10):1991-5. PubMed ID: 20683260
[TBL] [Abstract][Full Text] [Related]
19. Invasive community-associated MRSA infections: epidemiology and antimicrobial management.
Pichereau S; Rose WE
Expert Opin Pharmacother; 2010 Dec; 11(18):3009-25. PubMed ID: 20955116
[TBL] [Abstract][Full Text] [Related]
20. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors.
Shapiro A; Raman S; Johnson M; Piehl M
N C Med J; 2009; 70(2):102-7. PubMed ID: 19489364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
